These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 104684)

  • 21. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(5):487-95. PubMed ID: 94405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A; Ziacchi V; Lomanto B
    Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the cardiovascular effects of the beta-blockader atenolol].
    Lucatti A; Delfino R; Musso G; Gazzarata M; Oldoino E; Spirito P
    Arch Sci Med (Torino); 1983; 140(2):177-82. PubMed ID: 6882193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
    Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
    Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of atenolol on the heart size, on the heart rate, and on the blood pressure at rest (author's transl)].
    Frisch P
    Med Klin; 1978 Oct; 73(42):1477-80. PubMed ID: 703677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of propranolol and metipranolol on systolic time intervals in health volunteers].
    Smíd J; Cepelák V; Mayer O
    Vnitr Lek; 1981 Jul; 27(7):683-90. PubMed ID: 6117982
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of atenolol in moderate arterial hypertension. Evaluation by stress test].
    Arrieta JA; Alegría E; Huguet R; Larraz MP; Calabuig J; Martínez Caro D
    Rev Med Univ Navarra; 1987; 31(1):23-8. PubMed ID: 3616360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Circulation; 1980 Nov; 62(5):1036-45. PubMed ID: 7418154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():473s-475s. PubMed ID: 7449301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
    González-Gómez A; García-Barreto D; Cabrera R; Toruncha A; Hernández-Cañero A
    Pharmacology; 1982; 25(1):33-8. PubMed ID: 6289362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
    Erina EV; Charyev KhE; Oshchepkova EV
    Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systolic time intervals in essential arterial hypertension. Effects of beta-blockaders].
    Lehner JP; Kheder A; Levenson J; Simon A; Cadre N; Weiss Y; Safar M
    Coeur Med Interne; 1978; 17(1):89-94. PubMed ID: 25161
    [No Abstract]   [Full Text] [Related]  

  • 37. Pindolol in the treatment of hypertension: systolic time intervals as a predictor of response to beta receptor blockade.
    Plotnick GD; Fisher ML; Hamilton JH; Robinson M; Carliner NH; Janowski AH; Hamilton BP
    Am J Cardiol; 1980 Mar; 45(3):614-20. PubMed ID: 6243851
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of beta-adrenergic blocking drugs on the intrinsic beating rate of cultured rat myocytes.
    Higgins TJ; Allsopp D; Bailey PJ
    J Mol Cell Cardiol; 1979 Jan; 11(1):101-7. PubMed ID: 423253
    [No Abstract]   [Full Text] [Related]  

  • 39. [Affecting systolic time intervals with the beta-blocker methypranol (author's transl)].
    Stríz S; Inczinger F; Cagán S
    Bratisl Lek Listy; 1978 Aug; 70(2):155-64. PubMed ID: 28819
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodynamic factors and Rorschach testing in borderline and sustained hypertension.
    Safar ME; Kamieniecka HA; Levenson JA; Dimitriu VM; Pauleau NF
    Psychosom Med; 1978 Dec; 40(8):620-30. PubMed ID: 746106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.